PMB-CT01 (BAFFR-CAR T cell) therapy to examine preliminary safety and clinical responses in patients with B-cell malignancies who are ineligible for or failed CD19-directed therapy, including CD19-negative disease
Budde, Lihua Elizabeth, Del Real, Marissa, Baird, John H., Chen, Lu, Song, Joo Y, Wang, Xiuli, Kambhampati, Swetha, Macias, Alan, Kim, Teresa, Dulan, Sylvia, Barva, Baishakhi, Guan, Min, Espinosa, Ruby, Puverel, Sandrine, Tiemann, Katrin, Cheng, Hazel (Ting-Ying), Forman, Stephen J., Kwak, Larry W., Aldoss, Ibrahim
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Development and characterization of a low-affinity humanized CD19-chimeric antigen receptor for B cell malignancies
Stern, Lawrence A., Vyas, Vibhuti, Lim, Laura, Huynh, Christian, Urak, Ryan, Espinosa, Ruby, Wang, Zhiqiang, Thiel, Michalina Silva, Williams, John C, Forman, Stephen J, Brown, Christine E, Wang, Xiuli
Published in Blood Neoplasia (01.10.2024)
Published in Blood Neoplasia (01.10.2024)
Get full text
Journal Article